Multi-omics Study Identifies Major Sources of Variability in iPSC-Derived Neurons for Disease Modeling
Researchers analyzed induced pluripotent stem cells (iPSCs) differentiated into neurons across six molecular layers to identify sources of variability that limit their use as disease models. The study found that clonal variability was comparable to differences between patients, with neuronal differentiation state and metabolic activity being the dominant contributors to variation. These findings provide guidelines for improving iPSC-based disease modeling and biomarker discovery by accounting for and minimizing identified sources of variability.
A preprint study published on bioRxiv examined why iPSC-derived neurons show substantial unexplained variability despite their promise as patient-specific disease models. Researchers profiled three rare genetic disorders—Myotonic Dystrophy Type 1, chromodomain-DNA-helicase-binding protein 2-related disorder, and N-acetylneuraminic acid synthase deficiency—using comprehensive multi-omics analysis spanning genomics, epigenomics, transcriptomics, proteomics, metabolomics, and lipidomics. The analysis revealed that clonal variability (differences between cell lines derived from the same patient) was comparable to inter-patient differences, and that neuronal differentiation state and nutrient-driven metabolic activity were the primary drivers of observed variation across all molecular layers. The researchers also found that stochastic differences in DNA methylation during reprogramming partly explained clonal differences. By modeling and correcting for these sources of variation, the team improved detection of disease-associated molecular signatures, offering practical guidelines for study design and data analysis to enhance reliability of iPSC-based disease modeling.
What's missing
The study does not specify whether findings are generalizable to other cell types derived from iPSCs or to other genetic disorders beyond the three examined. Additionally, the preprint does not indicate whether the proposed corrections have been validated in independent cohorts or prospectively tested for biomarker discovery.
What different sources said
- bioRxivCenter
Dissecting the sources of variation in neuronally differentiated iPSC lines through multi-omics analysis
Related
Study reveals how replication protein A prevents unregulated DNA synthesis and maintains genome stability
Researchers using Xenopus egg extracts found that replication protein A (RPA) prevents spontaneous DNA priming on single-stranded DNA and blocks inappropriate recruitment of recombination factors. RPA is a critical DNA-binding protein that becomes depleted when cells produce excess single-stranded DNA, potentially leading to replication fork breakage. The findings clarify RPA's protective role in maintaining genome stability and suggest mechanisms by which RPA depletion could trigger genomic instability.
Study reveals mammalian RNA localization elements are large, complex, and multipartite structures
Researchers systematically analyzed tens of thousands of mutant RNA localization elements and found that functional elements controlling subcellular RNA positioning are approximately 200 nucleotides in size and contain multiple critical subsequences. The study used high-throughput mutagenesis in neuronal cells and verified findings with single-molecule microscopy in primary rat neurons. These findings advance understanding of how cells control RNA distribution, which is fundamental to cellular function and may have implications for developmental biology and disease mechanisms.
Leritrelvir Shows Enhanced Activity Against Drug-Resistant SARS-CoV-2 Variants, Study Finds
A new study demonstrates that leritrelvir, an antiviral drug approved in China, maintains stronger inhibitory activity against drug-resistant variants of the SARS-CoV-2 main protease compared to nirmatrelvir (used in Paxlovid). The research used biochemical, structural, and cellular analyses to show that leritrelvir binding restores the dimerization of protease mutants that have developed resistance to current treatments. The findings suggest leritrelvir could be a more effective treatment option as the virus continues to evolve resistance to existing antivirals.